|
Division of
Nephrology
Andreoli TE.
Edematous states. In: Nephrology, Hypertension, Dialysis,
Transplantation. Proceedings of the Budapest Nephrology
School. T. E. Andreoli, E. Ritz and L. Rosivall, Editors.
Hungarian Kidney Foundation. pp. 261‑277, 2005.
Andreoli, TE.
The hyperkalemic syndromes. In: Nephrology, Hypertension,
Dialysis, Transplantation. Proceedings of the Budapest
Nephrology School. T. E. Andreoli, E. Ritz and L. Rosivall,
Editors. Hungarian Kidney Foundation. pp. 279‑289, 2005.
Andreoli TE, Safirstein RL. Fluid
and electrolyte disorders. In: Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin IJ, editors.
Andreoli and Carpenter's Cecil Essentials of Medicine.
Seventh Edition. Philadelphia, PA:
Saunders; 2007. p. 285-303.
Andreoli,
T. E., Editor-in-Chief., Carpenter, C.C.J., Griggs,
R.C., Benjamin, I.J., Editors. Andreoli and Carpenter's Cecil
Essentials of Medicine, Seventh Edition. Philadelphia,
Pennsylvania: W. B. Saunders; 2007. 1258 p.
Andreoli,
T. E. . An Obituary for Steven C. Hebert, M. D.
Journal of the American Society of Nephrology 2008 July;
19(1247-1248).
Andreoli,
T.E. In Rememberance of Steven C. Hebert, M.D., An
Obituary. ISN News 2008. 26:12-13, June, 2008.
Apostolov EO,
Basnakian AG, Ok E,
Shah SV.
Quantification of carbamylated LDL in
human sera
using new sandwich ELISA assay. Clin Chem 2005;
51(4):719-728.
Apostolov EO,
Abu Al-Soud W, Nilsson I., Kornilovs’ka IN, Usenko VS, Lyzogubov
VV, Gaydar YuA, Wadström T, Ljungh Å. Helicobacter pylori and other
Helicobacter species in gallbladder and liver of patients with
chronic cholecystitis detected by immunological and molecular
methods. Scan J Gastroenetrology 2005; 40:96-102.
Apostolov EO,
Basnakian AG, Yin X, Ok E,
Shah SV. Modified LDLs induce
proliferation-mediated death of human vascular endothelial cells
through the mitogen-activating protein kinases (MAPK) pathway.
Am J Physiol Heart Cardiovasc 2007; 292(4): H1936-H1846.
Apostolov
EO, Shah SV, Ok E, Basnakian AG. Carbamylated LDL induces
monocyte adhesion to endothelial cells through ICAM-1 and
VCAM-1. Arterioscler Thromb Vasc Biol 2007; 27(4):826-32.
Apostolov
EO, Basnakian AG, Ok E, Shah SV. Carbamylated LDL and oxidized
LDL induce proliferation-mediated death of human vascular
endothelial cells. Am J Phys: Heart Vasc Circ 2007;
292(4):H1836-46.
Apostolov EO, Shah SV, Ok
E, Basnakian AG. Carbamylated LDL induces monocyte adhesion to
endothelial cells through ICAM-1 and VCAM-1. Arterioscler Thromb
Vasc Biol 2007; 27(4):826-32.
Arany, I,
Megyesi J, Reusch J,
Safirstein RL. CREB mediates
ERK-induced survival of mouse renal tubular cells after oxidant
stress. Kidney International 2005; 68(4), 1573-1582.
Arany I, Megyesi J, Nelkin BD,
Safirstein RL. STAT3 attenuates EGFR-mediated ERK
activation and cell survival during oxidant stress in mouse
proximal tubular cell. Kidney Int 2006; 70: 669-674.
Arany I., Faisal A., Yoshikuni N.,
Safirstein RL. P66SHC
inhibits the pro-survival EGFR/ERK signaling during sever
oxidative stress in mourse renal proximal tubule cells. J
Biol Chem 2008 283(10):6110-6117.
Banfalvi G, Gacsi
M, Nagy G, Kiss ZB,
Basnakian AG. Common pathway of chromosome condensation in
mammalian cells. DNA & Cell Biol 2006; 25(5): 295-301.
Banfalvi G,
Gacsi M, Nagy G, Kiss ZB, Basnakian AG.
Cadmium induced apoptotic changes in chromatin structure and
subphases of nuclear growth during the cell cycle in CHO cells.
Apoptosis 2005; 10, 3, 631-642.
Banfalvi G, Nagy
G, Basnakian AG. Supranucleosomal organization of chromatin
fibers in nuclei of Drosophila S2 cells. DNA & Cell Biol 2007;
26(1): 55-62.
Barone GW., Wright CF.,
Krause M., Brosnahan GM., Portilla D.,
Banerjee S., McCowan TC., Culp WC., Yousaf M. Hemodialysis
Access Success: Beyond the Operating Room. Amer J Surgery
2007 November; 194(5):668-671.
Basnakian AG,
Apostolov EO, Yin X,
Napirei M, Mannherz HG, Shah SV.
Cisplatin
nephrotoxicity is mediated by DNase I. J Am Soc Nephrol
2005; 16(3)697-702.
Basnakian AG, Ueda N,
Hong X, Galitovsky VE, Yin X, Shah SV.
Ceramide synthase is essential for endonuclease-mediated death
of renal tubular epithelial cells induced by hypoxia-reoxygenation.
Am J Physiol Renal Physiol 2005; 288, 2, F308-F314 (Epub
2004 Oct 12).
Basnakian
AG, Apostolov EO, Yin X, Abiri SO, Stewart AG, Singh AB,
Shah SV. Endonuclease G promotes cell death of non-invasive human
breast cancer cells. Exp Cell Res 2006; 312(20):4139-4149.
Basnakian AG, Sweatman TW, Wortsman
J, Elsner P, Slominski A Melatonin increases survival of HaCaT
keratinocytes by suppressing UV induced apoptosis, J Pineal Res
2006; 40(1): 18-26.
Basnakian AG.
Carbamylated LDL induces monocyte adhesion to endothelial cells
[Internet].
International
Atherosclerosis Society. http://www.athero.org.
Beger RD., Holland R., Sun J.,
Schnackenberg LK., Moore P., Dent CL., Devarajan P.,
Portilla D. Metabolomics of
acute kidney injury in children after cardiac surgery. Ped
Nephrology 2008 June; 23(6):977-984.
K.B. Udupa ,
Bose C. Identification of
erythroid Cell stimulating factor as a unique protein.Quiescin6:
role in erythropoiesis . Blood 2005; 106(11):4270.
Bose C,
Bhuvaneswaran C, Udupa KB. Age-related alteration in hepatic
acyl-CoA: cholesterol acyltransferase and its relation to LDL
receptor and MAPK. Mech Ageing Dev 2005 Jun; 126(6-7):740
- 751.
Bose C,
Zhang H, Udupa KB, Chowdhury P. Activation of
p-ERK1/2 by nicotine in pancreatic tumor cell line AR42J:
effects on proliferation and secretion. Am J Physiol
Gastrointest Liver Physiol 2005 Nov; 289(5):G926 - G934.
Bose C.,
Udupa KB. Erythropoetin enhancement of rat pancreatic tumor cell
proliferation requires the activation of erk and jnk signals..
Am J Physiol Cell Physiol 2008 June 11; Epub ahead of
print
Brosnahan G. Update of the PKD
Foundation's Booklet ,The Family and PKD: A Guide for Children and Parents [Internet].
PKD Foundation; 2006.
http://www.pkdcure.org.
Brosnahan GM. Volume progression
in polycystic kidney disease. N Engl J Med 2006;355: 733-734.
Chowdhury P,
Bose C, Udupa KB.
Nicotine-induced proliferation of isolated rat pancreatic acinar
cells: effect on cell signalling and function. Cell Prolif
2007 Feb; 40(1):125 - 141.
Couser WG,
Shah SV, World Kidney Day 2007 Steering Committee,
Kopple J, Beerkens, Wilson A,
Feehally J, Reiser T, Riella M. A call to action on World Kidney
Day, March 8 2007. Nephrology 2007; 12 (1): 1–2;
J
Am Soc Nephrol 2007; 18:374-378; Am J
Kidney Dis 2007; 49:175-79; Pediatr Nephrol 2007; 3:321-325.
Dong X.,
Swaminathan S., Bachman LA., Coatt AJ., Nath KA.,
Griffin MD. Resident Dendritic Cells are the Predominant TNF-a
Secreting Cell After Renal Ischemia-Reperfusion Injury.
Kidney Int 2007 (71):619-28.
Fang, Y., Megyesi J,
Safirstein RL, Price PM. Identification of the
functional domain of p21 that protects from cisplatin
cytotoxicity. Am J Physiol Renal Physiol 2005;
289:F514-20.
Fischer TW, Zbytek B, Sayre RM,
Apostolov EO, Basnakian AG, Sweatman TW,
Wortsman J, Elsner P, Slominski A. Melatonin increases survival
of HaCaT keratinocytes by suppressing UV-induced apoptosis. J
Pineal Res 2006 Jan;40(1):18-26.
Gacsi M, Nagy G, Pinter G, Basnakian
AG, Banfalvi G. Condensation of interphase
chromatin in nuclei of synchronized Chinese hamster ovary
(CHO-K1) cells. DNA and Cell Biology 2005;24, 1, 43-53.
Gilbert,K.M., S.R.Boger,
Price P, and E.K.Fifer.
2005. T cell tolerance induced by histone deacetylase inhibitor
is mediated by p21cip1. Immunopharmacol Immunotoxicol 2005; 27: 545-564.
Gokden N, Neslihan C, Nagihan C,
Kumar J,
Abul‑Ezz
S,
Barlogie B, Liapis H, Walker P; Morphologic Manifestations of
Combined Light‑Chain Deposition Disease and Light‑Chain Cast
Nephropathy. Ultrastructural Pathol 2007; 31:141‑149.
Hansberry MR,
Whittier WL, Krause MW. The
elderly patient with chronic kidney disease. Advances in Chronic
Kidney Disease. Advances in Chronic Kidney Disease 2005;
12(1):71-77.
Herzog C, Kaushal GP, and
Haun RS, Generation of biologically active interleukin-1 by
meprin B. Cytokine 2005; 31 394-403.
Herzog, C,
Seth R, Shah SV, and Kaushal GP. Role of meprin A in renal
tubular epithelial cell injury. Kidney Int 2007; 71:1009-1018.
Jones CA,
Krowlewski AS, Rogus J, Xue JL, Collins A, Warram JH.
Perspectives in
Renal Medicine: Epidemic of end-stage renal disease in people
with diabetes in the United States population: Do we know the
cause? Kidney Int 2005 May;67(5)1684-91.
Kaushal GP, Portilla D, and
Shah SV. Antiapoptotic Agents. In:
Ronco C, Bellomo R, Kellum J, editors. Critical Care Nephrology. 2nd
Edition. Philadelphia, PA: Exselvier; 2007.
Kaushal GP.,
Kaushal V., Herzog C., C YANG
. Autophagy delays apoptosis in renal tubular epithelial cells
in cisplatin cytotoxicity. Autophagy 2008; 4 (5):710-12.
Krause MW,
Shah SV. Pregnancy complicated by Renal Disorders.
Chapter in Clinical Obstetrics: The Fetus and Mother, 3rd
Edition. Blackwell Publishing, 2005.
Krause MW,
Walker PD. Glomerular Diseases. Chapter in Andreoli and
Carpenter’s Cecil Essentials of Medicine VII, WB Saunders
Publishing, 2005.
Krause MW,
Shah SV. Approach to the Patient with Renal
Disease. Chapter in Andreoli and Carpenter’s Cecil Essentials
of Medicine VII, WB Saunders Publishing, 2005.
Krause MW. Evaluation of kidney
function, Nephrolithiasis, Tubulointerstitial Disorders. Sections of Medical Knowledge
Self Assessment Program (MKSAP) 14. American College of Physicians, 2006.
Krause MW, Alam M.
Peritoneal Dialysis Solutions, UptoDate, 2006 to present.
www.uptodate.com.
Krause MW, Walker PD. Glomerular
Diseases. In: Andreoli TE,
Carpenter CCJ,
Griggs RC, Benjamin IJ, editors.
Andreoli and Carpenter's Cecil Essentials of Medicine.
Seventh Edition. Philadelphia, PA: Saunders; 2007.
Krause MW, Shah SV. Approach to
the Patient with Renal Disease. In: Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin IJ,
editors. Andreoli and Carpenter's Cecil Essentials of
Medicine. Seventh Edition. Philadelphia,
PA: Saunders; 2007. p. 278-284.
Krause MW, Shah SV. Pregnancy complicated by renal disorders.
In: Reece AE, Hobbins J, editors. Clinical Obstetrics: the Fetus & Mother. 3rd
Edition. Oxford, UK: Blackwell Publishing Ltd.;
2007.
Krause M.
Medical Knowledge Self Assessment Program (MKSAP). 15 ed.
American College of Physicians; 2007-2009. Evaluation of Kidney
Function.
Krause M.
Medical Knowledge Self Assessment Program (MKSAP). 15
ed. American College of Physicians; 2007-2009. Nephrolithiasis.
Krause M.
Medical Knowledge Self Assessment Program (MKSAP). 15 ed.
American College of Physicians; 2007-2009. Tubulointerstitial
Disorders.
Kumar
J, Shaver MJ, Abul-Ezz S. Long-term remission of
recurrent Parvovirus-B-associated anemia in a renal transplant
recipient induced by treatment with immunoglobulin and positive
seroconversion. Journal of Transplant Infectious Diseases
2005; 7(1) :30-33.
Kumar J, Shah SV.
Kidney disease as an independent risk factor for cardiovascular
events. J Re Nutr 2005; 15(1):99-104.
Kumar J.,
Abul-Ezz S., Andreoli TE (Ed)., Carpenter CCJ (Ed).
Cecil Essentials of Medicine. Seventh ed. Philadelphia, PA: W.B.
Saunders, Co Publishers; 2007. Chronic Renal Failure.
Li S, Gokden N, Okusa M, Bhatt R,
Portilla
D.
Anti-inflammatory effect of fibrate protects from cisplatin
induced ARF. Am J of Physiol Renal Physiol 2005; 289:
F469-F480.
Mehta RL, Kellum JA,
Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A.
Acute
Kidney Injury Network (AKIN): report of an initiative to improve
outcomes in acute kidney injury.
Crit Care 2007;
11(2):R31.
Mitchell
LA, Bradsher RW Jr, Paden TC, Malak SF, Warmack TS, Nazarian SM,
Fitzgerald RT, Bansal D, Carrouth DA, Khan MA,
Shah SV.
Tularemia induced bilateral optic neuritis. J Ark Med Soc 2006;
102(9):246-9.
Misra S.,
Gyamlani G., Swaminathan S.,
et al. Safety and Diagnostic Yield of Transjugular Renal Biopsy.
J Vasc Interv Radiol 2008 19(4):546-51.
Nádasi E,
Anga B, Sándor J, Megyesi J, Kelemen D, Mottolese M, Natali PG,
Hegedüs G, Arany I, Ember I. Prognostic factors in Hungarian
breast cancer patients. Anticancer Res 2007; 27: 279-282.
Nagothu KK., Bhatt
R, Kaushal GP, Portilla D Fibrate prevents cisplatin-induced
proximal tubule cell death. Kid Int 2005; 68:
2680-2693.
Napirei M, Basnakian AG, Apostolov EO, Mannherz HG.
Deoxyribonuclease 1 aggravates
acetaminophen-induced liver necrosis in male CD-1 mice.
Hepatology 2006; 43(2):297-305.
Negishi K., Noiri E., Sugaya T.,
Li S., Megyesi JK., Nagothu K.,
Portilla D. A Role of Liver
Fatty Acid-binding Protein in Cisplatin-induced Acute Renal
Failure. Kidney Int 2007 72:348-358.
Negishi K., Noiri E., Sugaya T.,
Li S., Megyesi J., Nagothu K.,
Portilla D. A Role of Liver
Fatty Acid-binding Protein in Cisplatin-induced Acute Renal
Failure. Kidney International 2007 7:348-358.
Negishi K., Noiri E., Maeda R.,
Portilla D., Sugaya T., Fujita
T. Renal L-type fatty acid binding protein mediates bezafibrate-induced
protection against cisplatin-induced acture kidney injury.
Kidney Int 2008 March; 73:1374-1384.
Ok
E, Basnakian AG, Apostolov EO,
Barri YM, Shah SV.
Carbamylated LDL induces
proliferation
and death of endothelial cells: a link to atherosclerosis.
Kidney Int, 2005, 68:1–6.
Panesar M,
Kumar J, Abul-Ezz S.
Outcome of renal transplantation from older donors. (letter).
NEJM. 354(19): 2072, 2006.
Portilla D, Okusa
M.D. T cells and Tcell receptors in acute renal failure. Kid
Int 2006; 69:208-210.
Portilla D,
Li S, Nagothu KK,
Megyesi J, Kaissling B, Schackenberg L,
Safirstein RL, Beger RD. Metabolomic study of cisplatin-induced
nephrotoxicity. Kid Int 2006; 69: 2194-2204.
Portilla D, Kaushal GP, Basnakian AG,
Shah SV. Recent Progress
in the Pathophysiology of Acute
Renal Failure, In: Marschall S, Peterson R, Peterson C, editors.
Principles of Molecular Medicine. Second Edition. Totawa, NJ: Humana Press, Inc. 2006.
p. 643-649.
Portilla D,
Andreoli TE. Disorders of Extracellular Volume. In: Richard J
Johnson, editor. Textbook of
Nephrology.
2006.
Portilla D, Andreoli TE.
Disorders of extracellular volume. In: Johnson RJ, Feehally J.
editors.Comprehensive Clinical
Nephrology. London:
Mosby International. 2007. p. 77-91.
Portilla D, Shah
SV. Acute Renal Failure. In: Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin IJ, editors. Andreoli and
Carpenter's Cecil Essentials of Medicine. Seventh Edition.
Philadelphia, PA: Saunders; 2007.
Portilla D, Shah SV. Acute
kidney injury. In: Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin IJ, editors. Andreoli and
Carpenter's Cecil Essentials of Medicine. Seventh Edition.
Philadelphia, PA:
Saunders; 2007. p.
332-341.
Portilla
D., Schnackenberg L., Beger RD. Metabolomics in AKI
in Biomarkers of Renal Disease. Nova Publications; 2007.
Portilla D.,
Dent C., Sugaya T., Nagothu K., Moore P., Noiri E., Deverajan P.
Liver fatty acid binding protein as a biomarker of acute kidney
injury after cardiac surgery. Kidney Int 2008 Feb;
73(4):465-472.
Price PM
Diabetes: Caught in the Akt? Kidney Int 2007; 71: 839-841.
Reeves, W. B.,
Andreoli, T. E. Sodium chloride
transport in the loop of Henle, distal convoluted tubule, and
collecting duct. In: The Kidney: Physiology and Pathophysiology,
S.C. Hebert and R.J. Alpern, Editors. Fourth ed. Philadelphia:
Elsevier, p. 849-887; 2007.
Reeves, W. B.,
Andreoli, T. E. Tubular sodium transport. In:
Diseases of the Kidney and Urinary Tract, R.W. Schrier, Editor.
Eighth ed. Philadelphia: Lippincott Williams & Wilkins, p.
124-159; 2007.
Roszer T,
Kappelmayer J, Nagy GG, Szentmiklosi AJ,
Basnakian AG, Banfalvi
G. The neuropeptide FMRF amide can protect cells against cell
death in the snail digestive gland. Apoptosis 2006; 11,
175-182.
Rosner MH.,
Portilla D., Okusa MD. Cardiac
surgery as a cause of acute kidney injury: pathogenesis and
potential therapies.. J Intensive Care Med. 2008 Jan/Feb;
23(1):3-18.
Saba H., Batinic-Haberle I., Munusay
S., Mitchell T., Lichti C., Megyesi JK.,
MacMillen-Crow LA. Manganese Porphyrine Reduces Renal Injury and
Mitochondrial Damage During Ischemia/Reperfusion. Free
Radical Biology and Medicine 2007 42:1571-1578.
Safirstein
RL. Renal diseases induced by anti-neoplastic agents.
In: Diseases of the Kidney, 7th edition,
Schrier
and Gottschalk’s (eds), 2005, Little, Brown and Company,
Boston, MA.
Seth R, Yang C, Kaushal V, Shah SV,
Kaushal GP. p53-dependent
caspase-2 activation
in
mitochondrial release of apoptosis inducing factor and its role
in renal tubular epithelial cell injury. J Biol Chem
2005; 280: 31230-31239.
Shah SV. Oxidants and iron in progressive kidney disease.
J
Renal Nutr 2006;16(3):185-9.
Shah
SV, Baliga R, Fonseca VA, Rajapurkar M. Oxidants in chronic
kidney disease. J Am Soc Nephrol 2007; 18(1):16-28.
Swaminathan S
and Nelson Leung. Nephrogenic Fibrosing Dermopathy: Lessons from
the past. Int J Dermatol 2006; 45: 639-41.
Swaminathan S, Ahmed I,
McCarthy JT, et al. Nephrogenic fibrosing dermopathy is high
dose erythropoietin therapy. Ann Intern Med 2006;
145:234-5.
Swaminathan S, Lager D, Leung
N, et al. Changing incidence of glomerulonephritis in Olmsted
County, Minnesota: A 30 year renal biopsy study. Clin J Am
Soc Nephrol 2006; 1:483-86.
Swaminathan S, Lager DJ, Qian
X, Stegall MD, Larson TS, Griffin MD. Collapsing and non on-collapsing focal segmental glomerulosclerosis in kidney
transplants. Nephrol Dial Transplant 2006; 21:2607-2614.
Swaminathan
S., Horn TD., Pellowski D.,
Abul-Ezz S., Bornhorst JA., Viswamitra S.,
Shah SV. Nephrogenic Systemic
Fibrosis, Gadolinium and Iron Mobilization. N Engl J Med
2007 357:720-22.
Swaminathan
S., Fonseca VA.,
Alam MG., Shah SV. Role of Iron
in Diabetes and Its Complications. Diabetes Care 2007
(71):1926-1933.
Swaminathan
S., High W., Ranville J., Horn TD.,
Brown H., Thomas M., Shah SV.
Cardiac and Vascular Metal Deposition and High Mortality in
Nephrogenic Systemic Fibrosis. Kidney Int. 2008 April;
73:1413-1418.
Swaminathan
S., Shah SV. Novel Insights into Nephrogenic Systemic
Fibrosis. J Am Soc Nephrol 2007 (18):2636-43.
Swaminathan
S., Shah SV. Novel Approaches Targeted Toward
Oxidative Stress for the Treatment of Chronic Kidney Disease.
Curr Opinion Nephrol Hypertens 2008 17(2):143-8.
Tanaka T., Noiri E., Yamamoto T.,
Sugaya T., Negishi K., Maeda R., Nakamura K.,
Portilla D., Goto M., Fujita
T. Urinay Human L-FABP is a potential biomarker to predict
Cox-inhibitor-induced renal injury. Nephron: Exp Nephrol
2008 108(1):e19-26.
Tiwari MM, Brock RW, Megyesi
JK, Kaushal GP, Mayeux PR. Disruption of
renal peritubular blood flow in lipopolysaccharide-induced renal
failure: Roles of nitric oxide and caspases. Am J Physiol
Renal Physiol 2005; 68(6):2680-93.
Wang X., Tryndyak V.,
Apostolov EO., Yin X.,
Shah SV., Pogribny IP.,
Basnakian AG. Sensitivity of
human prostate cancer cells to chemotherapeutic drugs depends on
EndoG expression regulated by promoter methylation.. Cancer
Lett 2008 270(1):132-143.
Wangila GW, Nagothu KK, Steward R
3rd, Bhatt R, Lyere PA, Willingham WM, Sorenson JR, Shah SV,
Portilla D. Prevention of cisplatin-induced kidneyepithelial
cell apoptosis with a Cu superoxide dismutase-mimetic [copper
211(3,5 ditertiarybutylsalicylate)(4)ethanol4]. Toxicol In
Vitro 2006; 20(8):1300-12.
Weber, K. T., Hefner, L. L., Rackley,
C. E., Russell, R. O., Andreoli, T. E.
In Memoriam. T. Joseph Reeves, M. D., 1923-2007. Circulation
2007 116:2356-2357, 2007.
Wei Q., Dong G., Yang T.,
Megyesi JK., Price PM., Dong Z.
Activation and Involvement of p53 in Cisplatin-induced
Nephrotoxicity. Am J Physiol Renal Physiol 2007 293:F1282-91.
Xu-Ping Wang,
Agnes B. Fogo, Selene Colon, Giovanna Giannico,
Sameh R. Abul-Ezz, Jeffrey
H. Miner, And Dorin-Bogdan Borza. Distinct Epitopes for Anti-Glomerular
Basement Membrane Alport Alloantibodies and Goodpasture
Autoantibodies within the Noncollagenous Domain of ( alpha)
3(IV) Collagen: A Janus-Faced Antigen. Journal of the
American Society of Nephrology 2005; 16 ( 12): 3565-3571.
Yang C,
Kaushal V, Shah SV, Kaushal GP. Mcl-1 is downregulated in
cisplatin-induced apoptosis, and proteasome inhibitors restore
Mcl-1 and promote survival in renal tubular epithelial cells. Am
J Physiol Renal Physiol 2007; 292(6):F1710-1717.
Yang C.,
Kaushal V., Shah SV., Kaushal G. Autophagy is
associated with apoptosis in cisplatin injury to renal tubular
epithelial cells. Am J Physiol Renal Physiol 2008 Feb;
294(4):F777-787.
Yang C.,
Kaushal V., Haun RS., Seth R.,
Shah SV., Kaushal G.
Transcriptional activation of caspase-6 and -7 genes by
cisplatin-induced p53 and its functional significance in
cisplatin nephrotoxicity. Cell Death and Dfferentiation 2008
15:530–544.
Yu,F.,
Megyesi J, Safirstein RL, Price
PM. Identification of the
functional domain of p21WAF1/Cip1 that protects from
cisplatin cytotoxicity. Am J Physiol Renal Physiol
2005; 289: F514-F520.
(Subject of Editorial Focus:Nath,K.A. 2005. The provenance of
the protective property of p21. Am J Physiol Renal Physiol
289: F512-F513).
Yu F.,
Megyesi JK., Safirstein RL., Price PM. The
Involvement of the cdk2-E2F1 Pathway in Cisplatin Cytotoxicity
in vitro and in vivo. Am J Physiol Renal Physiol 2007
293:F52-F59.
Yu F.,
Megyesi JK., Price PM. (In Press). Cytoplamic
Initiation of Cisplatin Cytotoxicity. Am J Physiol Renal
Physiol 2008
|
